Uploaded December 2024 | Updated September 2026, 1 week ago
You can view the presentation slides here:
files.wearesrna.org/symposia/2024_rnds/slides/2024RNDS_Schreiner.pdf
At the 2024 RNDS, Drs. Teri Schreiner, Michael Levy, and Grace Gombolay shared their expertise in pediatric and adult neuroimmunology, focusing on diagnosing and managing acute disseminated encephalomyelitis (ADEM) and MOG antibody disease (MOGAD) [00:00:53]. Dr. Schreiner provided a detailed overview of ADEM, including typical symptoms, diagnostic criteria, and treatment options [00:05:24]. Dr. Gombolay then explained MOGAD, comparing its symptoms and progression to those of other neuroimmune disorders such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) [00:17:24]. The session included a segment where panelists addressed audience questions about treatment efficacy, symptom management, and the challenges of insurance coverage for treatments like IVIG [00:28:36]. Please note that the information shared during this session is for informational purposes only and is not medical advice.
00:00 Welcome and Introductions
02:15 Overview of ADEM
12:15 Understanding MOGAD
17:24 Comparing ADEM, MOGAD, and MS
21:22 Treatment and Recovery
28:36 Questions and Discussions
40:21 Understanding Drug Delivery Systems
40:29 Steroid Dosing Mysteries
40:54 Steroid Side Effects and Alternatives
41:41 MRI Findings in Neuroimmunology
42:59 Diagnosing MOGAD vs. NMOSD
46:27 International Perspectives on MOGAD Treatment
49:24 Managing Fatigue in Neuroimmune Disorders
01:02:39 Challenges with Insurance for IVIG Treatment
01:09:58 Navigating Relapses and Treatment Options
You can view the presentation slides here:
files.wearesrna.org/symposia/2024_rnds/slides/2024RNDS_Schreiner.pdf
At the 2024 RNDS, Drs. Teri Schreiner, Michael Levy, and Grace Gombolay shared their expertise in pediatric and adult neuroimmunology, focusing on diagnosing and managing acute disseminated encephalomyelitis (ADEM) and MOG antibody disease (MOGAD) [00:00:53]. Dr. Schreiner provided a detailed overview of ADEM, including typical symptoms, diagnostic criteria, and treatment options [00:05:24]. Dr. Gombolay then explained MOGAD, comparing its symptoms and progression to those of other neuroimmune disorders such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) [00:17:24]. The session included a segment where panelists addressed audience questions about treatment efficacy, symptom management, and the challenges of insurance coverage for treatments like IVIG [00:28:36]. Please note that the information shared during this session is for informational purposes only and is not medical advice.
00:00 Welcome and Introductions
02:15 Overview of ADEM
12:15 Understanding MOGAD
17:24 Comparing ADEM, MOGAD, and MS
21:22 Treatment and Recovery
28:36 Questions and Discussions
40:21 Understanding Drug Delivery Systems
40:29 Steroid Dosing Mysteries
40:54 Steroid Side Effects and Alternatives
41:41 MRI Findings in Neuroimmunology
42:59 Diagnosing MOGAD vs. NMOSD
46:27 International Perspectives on MOGAD Treatment
49:24 Managing Fatigue in Neuroimmune Disorders
01:02:39 Challenges with Insurance for IVIG Treatment
01:09:58 Navigating Relapses and Treatment Options
